However, further investigations are needed to fully understand the effectiveness of SGLT2i and GLP1-RA in promoting reverse cardiac remodeling and attenuating the inflammatory and fibrotic processes underlying heart failure, particularly in the context of diabetes. This evidence concerns the gene GCG and diabetes mellitus.